Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Current Opinion in Virology|April 4, 2024
Inhaled aerosol viral-vectored vaccines against tuberculosisElena Stylianou, Iman Satti
Scientific Reports|May 11, 2026
Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosisTheerawat Dorbutr, Elena Stylianou, Helen McShane, et al.
Inflammation & Allergy Drug Targets|March 12, 2009
TNF-alpha in tuberculosis: a cytokine with a split personalityAmanda Mootoo, Elena Stylianou, Mauricio A Arias, et al.
Expert Review of Vaccines|December 27, 2019
Mucosal delivery of tuberculosis vaccines: a review of current approaches and challengesElena Stylianou, Matthew J Paul, Rajko Reljic, et al.
Cytokine|May 4, 2010
Cytokine interactions that determine the outcome of Mycobacterial infection of macrophagesRajko Reljic, Elena Stylianou, Sucharitha Balu, et al.
Frontiers in Immunology|October 23, 2023
A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challengeElena Stylianou, Nawamin Pinpathomrat, Oliver Sampson, et al.
Vaccine|February 7, 2021
Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine modelNawamin Pinpathomrat, Naomi Bull, Janet Pasricha, et al.
Frontiers in Immunology|February 28, 2025
Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosisChristopher J De Voss, Marcellus Korompis, Shuailin Li, et al.
Frontiers in Immunology|May 6, 2026
Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cellsMarcellus Korompis, Christopher J De Voss, Shuailin Li, et al.
Tuberculosis (Edinburgh, Scotland)|February 28, 2014
Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosisHazel C Poyntz, Elena Stylianou, Kristin L Griffiths, et al.
Pageof 5